Aptahem
0,85 SEK
-16,06 %
APTA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Aptahem operates in the pharmaceutical industry. The company develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's lead candidate is being developed as an emergency drug intended to prevent the onset of life-threatening organ and tissue damage in patients suffering from sepsis. A large part of the research is carried out in collaboration with partners in the industry. The company was founded in 2014 and is headquartered in Malmö.
Læs mereOmsætning og EBIT-margin
Omsætning
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
Årsrapport '25
Generalforsamling '26
Aptahem's webinar "Strategic Direction and Planned US Listing" now available
Aptahem Announces English-Language Webinar on Strategic Direction and Planned U.S. Listing
Bliv en del af Inderes community
Gå ikke glip af noget - opret en konto og få alle de mulige fordele